UNCLASSIFIED
ARCHIVED Skip navigation. To Contents     To Appendix A     To Appendix C     To Publications Page     To Home Page

Appendix B: Tables

Table B1. Trends in Percentage of Past Year Drug Use, 2004-2008

Table B2. Admissions to Publicly Funded Treatment Facilities, by Primary Substance, 2003-2007

Table B3. Drugs Distribution in the United States, by DTOs and OCDETF Region

Table B4. Gangs with Significant Influence on U.S. Drug Markets

Table B5. Pseudoephedrine Scheduling by State


Table B1. Trends in Percentage of Past Year Drug Use, 2004-2008

  2004 2005 2006 2007 2008
Cocaine (any form)
Individuals (12 and older) 2.4 2.3 2.5 2.3 2.1
Adolescents (12-17) 1.6 1.7 1.6 1.5 1.2
Adults (18-25) 6.6 6.9 6.9 6.4 5.5
Adults (26 and older) 1.7 1.5 1.8 1.7 1.6
Crack
Individuals (12 and older) 0.5 0.6 0.6 0.6 0.4
Adolescents (12-17) 0.3 0.2 0.3 0.3 0.1
Adults (18-25) 0.8 1.0 0.9 0.8 0.6
Adults (26 and older) 0.5 0.5 0.6 0.6 0.4
Heroin
Individuals (12 and older) 0.2 0.2 0.2 0.1 0.2
Adolescents (12-17) 0.2 0.1 0.1 0.1 0.2
Adults (18-25) 0.4 0.5 0.4 0.4 0.4
Adults (26 and older) 0.1 0.1 0.2 0.1 0.1
Marijuana
Individuals (12 and older) 10.6 10.4 10.3 10.1 10.3
Adolescents (12-17) 14.5 13.3 13.2 12.5 13.0
Adults (18-25) 27.8 28.0 28.0 27.5 27.6
Adults (26 and older) 7.0 6.9 6.8 6.8 7.0
Methamphetamine
Individuals (12 and older) 0.8 0.7 0.8 0.5 0.3
Adolescents (12-17) 0.7 0.7 0.7 0.5 0.4
Adults (18-25) 1.9 1.8 1.7 1.2 0.8
Adults (26 and older) 0.6 0.5 0.6 0.4 0.3
Prescription Narcotics
Individuals (12 and older) 4.7 4.9 5.1 5.0 4.8
Adolescents (12-17) 7.4 6.9 7.2 6.7 6.5
Adults (18-25) 11.9 12.4 12.4 12.1 12.0
Adults (26 and older) 3.0 3.3 3.6 3.6 3.3
LSD
Individuals (12 and older) 0.2 0.2 0.3 0.3 0.3
Adolescents (12-17) 0.6 0.6 0.4 0.5 0.7
Adults (18-25) 1.0 1.0 1.2 1.1 1.5
Adults (26 and older) 0.1 0.0 0.1 0.1 0.1
MDMA
Individuals (12 and older) 0.8 0.8 0.9 0.9 0.9
Adolescents (12-17) 1.2 1.0 1.2 1.3 1.4
Adults (18-25) 3.1 3.1 3.8 3.5 3.9
Adults (26 and older) 0.3 0.4 0.3 0.3 0.3
PCP
Individuals (12 and older) 0.1 0.1 0.1 0.1 0.0
Adolescents (12-17) 0.3 0.3 0.2 0.2 0.2
Adults (18-25) 0.3 0.2 0.2 0.2 0.1
Adults (26 and older) 0.0 0.0 0.0 0.0 *

Source: National survey on Drug Use and Health.
*Low precision; no estimate reported.

 

Table B2. Admissions to Publicly Funded Treatment Facilities, by Primary Substance, 2003-2007

Drug 2003 2004 2005 2006 2007
Cocaine 254,687 249,478 266,420 262,720 234,772
Heroin 273,996 261,610 259,462 264,599 246,871
Marijuana 291,470 287,121 301,263 299,692 287,933
Methamphetamine 114,451 125,361 154,447 152,561 137,154
Barbiturates 1,337 1,303 1,380 1,046 1,013
Other opiates/synthetics 52,840 61,340 70,268 80,131 90,516
Tranquilizers 8,164 8,212 8,458 9,334 9,949

Source: Treatment Episode Data Set.

 

Table B3. Drugs Distribution in the United States, by DTOs and OCDETF Region

OCDETF/DTO Mexican Asian Colombian Dominican Cuban
Florida/Caribbean Cocaine
Heroin
Marijuana Methamphetamine
Marijuana
MDMA
Cocaine
Heroin
Cocaine
Heroin
Marijuana
Cocaine
Heroin
Marijuana
Great Lakes Cocaine
Heroin
Marijuana
Methamphetamine
Cocaine
Heroin
Marijuana
MDMA
Cocaine
Heroin
Cocaine
Heroin
--
Mid-Atlantic Cocaine
Heroin
Marijuana
Methamphetamine
Marijuana
MDMA
Cocaine
Heroin
Cocaine
Heroin
Marijuana
--
New England Cocaine
Heroin
Marijuana
Methamphetamine
Marijuana
MDMA
Methamphetamine
Cocaine
Heroin
Marijuana
Cocaine
Heroin
Marijuana
--
New York/New Jersey Cocaine
Heroin
Marijuana
MDMA
Methamphetamine
Heroin
Marijuana
MDMA
Cocaine
Heroin
Marijuana
Cocaine
Heroin
Marijuana
MDMA
--
Pacific Cocaine
Heroin
Marijuana
Methamphetamine
Marijuana
MDMA
Methamphetamine
-- -- --
Southeast Cocaine
Heroin
Marijuana
Methamphetamine
Marijuana
MDMA
-- Cocaine
Marijuana
Marijuana
Southwest Cocaine
Heroin
Marijuana
Methamphetamine
Cocaine
Marijuana
MDMA
Methamphetamine
Cocaine
Heroin
Marijuana
Methamphetamine
Cocaine Cocaine
Marijuana
Methamphetamine
West Central Cocaine
Heroin
Marijuana
Methamphetamine
Marijuana
MDMA
-- -- --

Source: Federal, state, and local law enforcement reporting.

 

Table B4. Gangs with Significant Influence on U.S. Drug Markets

Name Primary Areas of Operation Drugs Trafficked Affiliations (DTOs)
18th Street Pacific
Southwest
Methamphetamine Sinaloa
Tijuana
Bandidos Southwest
Pacific
Cocaine
Heroin
Marijuana
Methamphetamine
Juárez
Barrio Azteca Southwest Cocaine
Heroin
Marijuana
Methamphetamine
Juárez
Black Guerilla Family Pacific
Mid-Atlantic
Cocaine
Marijuana
Sinaloa
Bloods New England
New York/New Jersey
Southeast
Southwest
Pacific
Cocaine
Heroin
Marijuana
MDMA
Tijuana
Sinaloa
Crips New England
Southeast
Southwest
Pacific
Cocaine
Heroin
Marijuana
MDMA
Juárez
Florencia 13 Pacific
Southwest
Southeast
Cocaine
Heroin
Marijuana
Methamphetamine
Tijuana
Sinaloa
Gangster Disciples Great Lakes
Pacific
Southeast
West Central
Cocaine
Heroin
Marijuana
Sinaloa
Hells Angels Pacific
Southwest
New England
New York/New Jersey
Cocaine
Marijuana
MDMA
Sinaloa
Tijuana
Hermanos de Pistoleros Latinos Southwest Cocaine
Marijuana
Gulf Coast
Zetas
Latin Kings Florida
Great Lakes
New England
New York/New Jersey
Mid-Atlantic
Pacific
Southeast
Southwest
West Central
Cocaine
Heroin
Marijuana
MDMA
Juárez
Sinaloa
Gulf Coast
Ñeta Southeast
Mid-Atlantic
New England
New York/New Jersey
Cocaine
Marijuana
Unknown
Mara Salvatrucha Mid-Atlantic
New England
New York/New Jersey
Southeast
Southwest
West Central
Pacific
Cocaine
Heroin
Marijuana
Methamphetamine
Sinaloa
Gulf Coast
Zetas
Mexican Mafia Southwest
Pacific
Cocaine
Marijuana
Sinaloa
Tijuana
Zetas
Mexikanemi Southwest Cocaine
Marijuana
Methamphetamine
Gulf Coast
Zetas
Norteños Pacific
Southwest
Cocaine
Marijuana
Methamphetamine
Sinaloa
Tijuana
Sureños Pacific
Southwest
West Central
Southeast
Southeast
Cocaine
Heroin
Marijuana
Methamphetamine
Sinaloa
Tijuana
Tango Blast Southwest Cocaine
Marijuana
Gulf Coast
Zetas
Texas Syndicate Southwest Cocaine
Marijuana
Gulf Coast
Zetas
Tiny Rascal Gangsters New England
Pacific
Marijuana
MDMA
Asian DTOs
Vagos Pacific
Southwest
Cocaine
Marijuana
Tijuana

Source: United States Department of Justice, Attorney General's Report to Congress on Growth of Violent Street Gangs, in Suburban Areas, April 2000; High Intensity Drug Trafficking Area reporting.

 

Table B5. Pseudoephedrine Scheduling by State

State Currently Schedules
Pseudoephedrine
Currently Has
Point-of-Sale
Restrictions
Currently Has
Pseudoephedrine
Tracking Laws
AK No Quantity, Packaging No
AL No Quantity, Packaging, Display/Offer Yes
AR Schedule V Quantity, Packaging, Display/Offer Yes
AZ Schedule V Quantity In Legislature
CA No Quantity No
CO No Packaging No
CT No No No
DC No No No
DE No Quantity, Display/Offer No
FL No Quantity, Display/Offer Yes
GA Exempt Schedule V Quantity, Packaging In Legislature
HI No Quantity, Packaging, Display/Offer Yes
IA Schedule V Quantity, Display/Offer Yes
ID Schedule II Display/Offer No
IL Schedule V Quantity, Display/Offer Yes
IN No Quantity, Display/Offer In Legislature
KS Schedule V Quantity, Packaging, Display/Offer Yes
KY No Quantity Yes
LA Schedule V Quantity, Display/Offer Yes
MA No No No
MD No No In Legislature
ME Maine designates its four schedules of controlled substances as W, X, Y, and Z. Pseudoephedrine is classified as Z. Quantity, Packaging, and Display No
MI No Quantity, Display/Offer Yes
MN Schedule V Quantity, Packaging, Display/Offer Yes
MO Schedule V Quantity, Display/Offer Yes
MS No Quantity, Display/Offer Yes
MT No Quantity, Display/Offer No
NC Schedule VI1 Quantity, Packaging, Display/Offer Yes
ND No Quantity, Packaging, Display/Offer Yes
NE No Quantity, Packaging, Display/Offer No
NH No No No
NJ No Quantity No
NM Schedule V Quantity, Display/Offer Yes
NV Schedule III2 No No
NY No No No
OH No Quantity, Display/Offer Yes
OK Schedule V Quantity, Display/Offer Yes
OR Schedule III No No
PA No Quantity, Packaging, and Display In Legislature
PR/USVI No No No
RI No Quantity Yes
SC No Quantity, Packaging, Display/Offer Yes
SD No Quantity, Packaging, Display/Offer No
TN Schedule V Quantity, Packaging, Display/Offer Yes
TX No Quantity, Display/Offer Yes
UT No Quantity, Display/Offer Yes
VA No Quantity, Display/Offer In Legislature
VT No Quantity, Packaging, Display/Offer No
WA Schedule II3 Quantity, Packaging, Display/Offer Yes
WI Schedule V Quantity Yes
WV Schedule V Quantity, Display/Offer Yes
WY No Quantity, Packaging, Display/Offer No

1. NC Code 90-94.
2. Excludes drug products approved under federal law for over-the-counter sale.
3. Excludes "any drug or compound containing Pseudoephedrine...that [is] prepared for dispensing or over-the-counter distribution and [is] in compliance with the Federal Food, Drug and Cosmetic Act and applicable regulations."


To Top     To Contents     To Appendix A     To Appendix C

To Publications Page     To Home Page

Unclassified


End of page.